Associated Papers
Recessive genomic and phenotypic variation in consanguineous families with cerebral palsy.
Bisarad P et al.
Medrxiv : the Preprint Server for Health Sciences, 2025
41282771 (PubMed )
Supplement: media-1.xlsx › Supplementary_Table_3
A systematic review and functional in-silico analysis of genes and variants associated with amyotrophic lateral sclerosis.
Arreola-Aldape CA et al.
Frontiers in Neuroscience, 2025
40589786 (PubMed )
Supplement: Table_4.xlsx › ClinVar_query_results
Genetic and in silico analysis of Indian sporadic young onset patient with amyotrophic lateral sclerosis.
Roychowdhury S et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2024
ALS Identified: two-year findings from a sponsored ALS genetic testing program.
Goutman SA et al.
Annals of Clinical and Translational Neurology, 2024
39044379 (PubMed )
Supplement: ACN3-11-2201-s003.xlsx › ClinGen_VariantClassification
An atypical ALS with PSP-like symptoms caused by ANXA11 p.D40G mutation: A case report and literature review.
Zhang X et al.
Frontiers in Neurology, 2023
Emerging Roles for Phase Separation of RNA-Binding Proteins in Cellular Pathology of ALS.
Milicevic K et al.
Frontiers in Cell and Developmental Biology, 2022
ANXA11 mutations are associated with amyotrophic lateral sclerosis-frontotemporal dementia.
Wang Y et al.
Frontiers in Neurology, 2022
Clinical and genetic characteristics of amyotrophic lateral sclerosis patients with ANXA11 variants.
Sung W et al.
Brain Communications, 2022
ANXA11 mutations in ALS cause dysregulation of calcium homeostasis and stress granule dynamics.
Nahm M et al.
Science Translational Medicine, 2020
Select a paper to view details